Nyxoah Cash Flow Conversion Efficiency

Latest as of September 2025: -0.402x

Nyxoah cash flow conversion efficiency. Based on the latest financial reports, Nyxoah (NYXH) has a cash flow conversion efficiency ratio of -0.402x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-20.48 Million ≈ $-23.95 Million USD) by net assets (€50.95 Million ≈ $59.57 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Nyxoah (2017–2024)

Cash flow conversion efficiency of Nyxoah from 2017 to 2024. This chart illustrates how Nyxoah's cash flow conversion efficiency has evolved over time, based on yearly financial data. View NYXH live share price for real-time trading data and today's change.

Nyxoah Cash Flow Conversion Ratio Explained

Nyxoah cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Nyxoah Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nyxoah ranked by their cash flow conversion efficiency. Also see NYXH stock market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Dominari Holdings Inc. NASDAQ:DOMH	-0.452x
RMB Holdings Ltd JSE:RMH	-0.038x
Indo Thai Securities Limited NSE:INDOTHAI	0.032x
Osmanli Menkul Degerler AS IS:OSMEN	-0.129x
Cords Cable Industries Limited NSE:CORDSCABLE	0.132x
Fiyta Holdings Ltd SHE:200026	0.040x
Lesico Ltd TA:LSCO	0.226x
Odysight.ai Inc. Common Stock NASDAQ:ODYS	-0.256x

Annual Cash Flow Conversion Efficiency for Nyxoah (2017–2024)

The table below shows the annual cash flow conversion efficiency of Nyxoah from 2017 to 2024. Review NYXH free cash flow debt coverage to assess the company's free cash flow relative to its total liabilities.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€113.25 Million ≈ $132.41 Million	€-49.23 Million ≈ $-57.55 Million	-0.435x	+4.85%
2023-12-31	€98.02 Million ≈ $114.60 Million	€-44.78 Million ≈ $-52.35 Million	-0.457x	-91.15%
2022-12-31	€120.32 Million ≈ $140.67 Million	€-28.76 Million ≈ $-33.62 Million	-0.239x	-40.19%
2021-12-31	€148.62 Million ≈ $173.75 Million	€-25.34 Million ≈ $-29.62 Million	-0.170x	-141.38%
2020-12-31	€97.19 Million ≈ $113.63 Million	€-6.86 Million ≈ $-8.02 Million	-0.071x	+95.58%
2019-12-31	€3.71 Million ≈ $4.34 Million	€-5.93 Million ≈ $-6.94 Million	-1.598x	-105.20%
2018-12-31	€10.45 Million ≈ $12.22 Million	€-8.14 Million ≈ $-9.52 Million	-0.779x	+57.47%
2017-12-31	€4.53 Million ≈ $5.29 Million	€-8.29 Million ≈ $-9.69 Million	-1.831x	--

About Nyxoah

BR:NYXH Belgium Medical Instruments & Supplies

Market Cap

$39.74 Million

€33.99 Million EUR

Market Cap Rank

#22559 Global

#92 in Belgium

Share Price

€0.79

Change (1 day)

-4.70%

52-Week Range

€0.73 - €5.00

All Time High

€29.90